Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality*-Reference-Cited by-同舟云学术

Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality*

Published:2011-08 Issue:8 Volume:39 Page:1886-1895
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Zahar Jean-Ralph,Timsit Jean-Francois,Garrouste-Orgeas Maïté,Français Adrien,Vesim Aurélien,Descorps-Declere Adrien,Dubois Yohann,Souweine Bertrand,Haouache Hakim,Goldgran-Toledano Dany,Allaouchiche Bernard,Azoulay Elie,Adrie Christophe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference41 articles.

1. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost

2. Sepsis mortality prediction based on predisposition, infection and response

3. Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis

4. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

5. Effectiveness of Treatments for Severe Sepsis

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study;Scientific Reports;2024-08-06

2. Primary Infection Site as a Predictor of Sepsis Development in Emergency Department Patients;The Journal of Emergency Medicine;2024-08

3. Differentiation of Type 17 Mucosal-Associated Invariant T Cells in Circulation Contributes to the Severity of Sepsis;The American Journal of Pathology;2024-07

4. Actualités sur les durées de traitement et la désescalade antibiotique en infectiologie urinaire;Progrès en Urologie - FMC;2024-05

5. Treatment and Management of Acinetobacter Pneumonia: Lessons Learned from Recent World Event;Infection and Drug Resistance;2024-02